Insider trades
Stock that executives, directors and 10% owners bought and sold on the open market, from the Form 4s they file with the SEC within two business days. Grants, option exercises and shares sold to cover taxes are left out.
- $1.4B bought by 281 insiders at 188 companies
- $2.3B sold by 265 insiders outside a trading plan
- $3.1B sold by 585 insiders under 10b5-1 plans
- 10 companies where two or more insiders bought (30 days)
Biggest buys
Past month · by insider, all their filings added up
-
LENLennar CorporationBerkshire Hathaway Inc.10% owner · +1 joint filer$595M
-
KODKodiak Sciences IncBaker Bros. Advisors LPDirector · +5 joint filers$157M
-
CRBGCorebridge Financial Inc.Life Insurance Co Nippon10% owner$124M
-
GPIGroup 1 Automotive, Inc.Conifer Management, L.L.C.10% owner$115M
-
UUUUniversal Safety Products, Inc.Milton C Ault IIIDirector$92.5M
-
GMEGameStop CorporationRyan CohenCEO$54M
-
GRABGrab Holdings LimitedAnthony Ping Yeow TanCEO$29.9M
-
GSATGlobalstar, Inc.James Monroe IIIDirector$29.8M
-
COURCoursera, Inc.Pale Fire Capital SE10% owner · +4 joint filers$11.4M
-
CVCapsoVision, Inc.Eliyahou Et Al Harari10% owner$10M
Biggest sales
Past month · by insider, all their filings added up · planned sales marked
-
IHTInnSuites Hospitality TrustMarc E BergEVP & Secretary/Treasurer$361M
-
NVDANvidia Corporation ComMark A StevensDirector$300M
-
AVGOBroadcom Inc.Henry SamueliDirector$250M
-
UMCUnited Microelectronics CorporationChitung LiuCFO$229M
-
THTarget Hospitality Corp.TDR Capital II Investments LP10% owner · +9 joint filers$202M
-
ESTCElastic N.V.Steven SchuurmanDirector$135M
-
CRWDCrowdStrike Holdings, Inc.Burt W. PodbereCFO$134M
-
MEDPMedpace Holdings, Inc.August J. TroendleCEO$126M
-
NBISNebius Group N.V.Ophir NaveCOO$118M
-
BZKanzhun LimitedPeng Jonathan ZhaoCEO$110M
Cluster buying
Companies where two or more insiders bought on the open market in the last 30 days · most buyers first
-
Reuben S Leibowitz Director, Larry C Glasscock Director, Daniel C. Smith Director, Gary M Rodkin Director, +7 more
-
Daniel L Florness Director, Srilata Zaheer Director, Charles T Lauber Director, Trangsrud Teresa J Rasmussen Director, +3 more
-
Thomas Jon Hammond Director, Sandip I Patel CFO, John Martin Schaible Chair, David Craig Ridenhour President, +1 more
-
John B Williamson III Director, Robert B Johnston Director, Paul W Nester CEO, Lawrence T. Oliver Senior VP and Secretary, +1 more
-
Matthew G De Soto Director, Albert J. Evans Director, Joel L. Frank Director, Theodore W Mowery Director, +1 more
-
Milena Maria Pappa Director, Raffaele Zagari Director, Nikolaos Reskos COO, Charis Plakantonaki Chief Strategy Officer
-
Joseph D Sarafa Director, Brian J Roney CEO, James Grant Smith Director, Harold J Meloche CFO
-
Lewis H Titterton Jr. Director, Amit Kumar CEO, Michael Catelani CFO, Arnold M Baskies Director
-
Michael Jordan Osborn CEO, Gregory William Voorhies Director, Chris Riccardi Director, James W Bernau President
-
J Tutt Barrett Director, David E Housel Director, William F Ham Jr. Director, Shannon O'Donnell Senior Vice President
All insider trades
Newest filings first · one row per filing · every open-market buy and sale
-
Donald Allen Williams DirectorPALIPalisade Bio, Inc.Buy$29K 20,000 shares at $1.44 +1.3% to stakeTraded Oct 1–2 Filed Oct 5
-
Marshall Urist EVP, Research & InvestmentsRPRXRoyalty Pharma plcPlanned sale$236K 4,126 shares at $57.10 100% of stakeTraded Oct 5 Filed Oct 5
-
ADAR1 Capital Management, LLC 10% owner · +1 joint filerINMInMed Pharmaceuticals Inc.Buy$57K 42,920 shares at $1.33 +4.8% to stakeTraded Oct 1–5 Filed Oct 5
-
Mark Hopman Chief Commercial OfficerBBNXBeta Bionics, Inc.Planned sale$7,015 370 shares at $18.96 0.7% of stakeTraded Oct 1 Filed Oct 5
-
Ori Winitzer DirectorLCIDLcidPlanned sale$4,120 1,000 shares at $4.12 1.5% of stakeTraded Oct 1 Filed Oct 5
-
Sean P. Duffy CEOOMDAOmada Health, Inc.Planned sale$357K 17,258 shares at $20.68 4.3% of stakeTraded Oct 1 Filed Oct 5
-
Vincentelli Alberto Sangiovanni DirectorCDNSCadence Design Systems, Inc.Planned sale$438K 1,250 shares at $350.07 3.1% of stakeTraded Oct 1 Filed Oct 5
-
Sanjeev Aggarwal CEOMRAMEverspin Technologies, Inc.Sale$373K 19,572 shares at $19.08 2.3% of stakeTraded Oct 2 Filed Oct 5
-
Jeremy Fox-Geen CFOCRCLCircle Internet Group, Inc.Planned sale$364K 4,238 shares at $85.78 1.4% of stakeTraded Oct 2 Filed Oct 5
-
Roderick A. Larson CEOOIIOceaneering International, Inc.Planned sale$265K 6,000 shares at $44.16 1.5% of stakeTraded Oct 1 Filed Oct 5
-
Hossein Razzaghi Chief Commercial OfficerCRCLCircle Internet Group, Inc.Planned sale$157K 1,830 shares at $85.78 0.3% of stakeTraded Oct 2 Filed Oct 5
-
Tamara L Schulz Chief Accounting OfficerCRCLCircle Internet Group, Inc.Planned sale$102K 1,194 shares at $85.78 1.3% of stakeTraded Oct 2 Filed Oct 5
-
William Earl Cooper CFOMRAMEverspin Technologies, Inc.Sale$59K 3,115 shares at $19.08 2% of stakeTraded Oct 2 Filed Oct 5
-
Frederic Simon DirectorFROGJFrog Ltd.Planned sale$11.7M 120,000 shares at $97.24 4.2% of stakeTraded Oct 1 Filed Oct 5
-
Kyle Horgan Executive VP, SpecialtySUNBSunbelt Rentals Holdings, Inc.Buy$1,863 25 shares at $73.30 +<0.1% to stakeTraded Oct 1 Filed Oct 5
-
Jayme Mendal CEOEVEREverQuote, Inc.Planned sale$413K 20,980 shares at $19.69 3.6% of stakeTraded Oct 1 Filed Oct 5
-
Daniel J Rizzo EVP, Sales, Consulting, & SvcsVEEVVeeva Systems Inc.Sale$1.3M 4,841 shares at $276.51 39% of stakeTraded Oct 2 Filed Oct 5
-
Yury Gryzlov COOGDYNGrid Dynamics Holdings, Inc.Planned sale$11K 1,245 shares at $8.46 0.2% of stakeTraded Oct 2 Filed Oct 5
-
Luke Roy Swanson Chief Technology OfficerIBTAIbotta, Inc.Planned sale$473K 11,880 shares at $39.79Traded Oct 1 Filed Oct 5
-
Andrew Houston CEODBXDropbox, Inc.Planned sale$12M 354,300 shares at $34.01 100% of stakeTraded Oct 1 Filed Oct 5
-
J. Scott Garland DirectorELVNEnliven Therapeutics, Inc.Sale$607K 13,000 shares at $46.67 100% of stakeTraded Oct 1 Filed Oct 5
-
Sean Michael Dougherty Vice President, SalesMRAMEverspin Technologies, Inc.Sale$147K 7,691 shares at $19.08 7.1% of stakeTraded Oct 2 Filed Oct 5
-
Michael Stock CFOLBRTLiberty Energy Inc.Planned sale$61K 3,333 shares at $18.17 0.4% of stakeTraded Oct 1 Filed Oct 5
-
Martine A Rothblatt CEOUTHRUnited Therapeutics CorporationPlanned sale$5.2M 9,500 shares at $549.37 2.8% of stakeTraded Oct 2 Filed Oct 5
-
Dominic Phillips See RemarksIOTSamsara Inc.Planned sale$1.2M 29,972 shares at $38.97Traded Oct 1 Filed Oct 5
-
Life Insurance Co Nippon 10% ownerCRBGCorebridge Financial Inc.Buy$9M 272,208 shares at $33.07 +0.2% to stakeTraded Oct 1 Filed Oct 5
-
Noel Joseph Spiegel DirectorAEOAmerican Eagle Outfitters, Inc.Sale$64K 3,617 shares at $17.68 100% of stakeTraded Oct 2 Filed Oct 5
-
Josh Silverman ChairETSYEtsyPlanned sale$151K 2,090 shares at $72.45 0.8% of stakeTraded Oct 1 Filed Oct 5
-
Ambra R. Roth SVP, GC and SecretaryMTSIMACOM Technology Solutions Holdings, Inc.Planned sale$196K 653 shares at $300.00 6.6% of stakeTraded Oct 1 Filed Oct 5
-
Jonathan R Root CFOHOGHarley-Davidson, Inc.Planned sale$38K 1,559 shares at $24.43 5.9% of stakeTraded Oct 1 Filed Oct 5
-
Ashim Gupta COOPATHUiPath, Inc.Planned sale$870K 66,052 shares at $13.17 3.4% of stakeTraded Oct 2 Filed Oct 5
-
K Charles Janac CEOAIPArteris, Inc.Planned sale$2.4M 100,000 shares at $23.82 1.2% of stakeTraded Oct 1 Filed Oct 5
-
Paul L Alpern VP and General CounselAIPArteris, Inc.Planned sale$155K 6,500 shares at $23.84 8.4% of stakeTraded Oct 1 Filed Oct 5
-
Jonathan Vassil Chief Revenue OfficerTOSTToast, Inc.Planned sale$200K 6,657 shares at $30.03 7.9% of stakeTraded Oct 2 Filed Oct 5
-
Vivek Jain Chief Operations/Tech OfficerADIAnalog Devices, Inc.Sale$834K 2,000 shares at $416.98 4.2% of stakeTraded Oct 2 Filed Oct 5
-
Alejandro Gustavo Elsztain DirectorLNDBrasilagro Cia Brasileira De Propriedades AgricolasBuy$200K 56,750 shares at $3.52 +8.5% to stakeTraded Sep 30–Oct 5 Filed Oct 5
-
Stephan D Memmen DirectorAIRGAirgain, Inc.Buy$6,825 1,500 shares at $4.55 +2.7% to stakeTraded Oct 2 Filed Oct 5
-
Katsufumi Nakamura Chief Customer OfficerADIAnalog Devices, Inc.Sale$498K 1,200 shares at $415.02 7.5% of stakeTraded Oct 2 Filed Oct 5
-
Vincent Roche CEOADIAnalog Devices, Inc.Planned sale$4M 10,000 shares at $396.94 8% of stakeTraded Oct 1 Filed Oct 5
-
Phil E Mulacek DirectorEPEmpire Petroleum CorporationBuy$27K 11,915 shares at $2.25 +1.3% to stakeTraded Sep 30 Filed Oct 5
-
David A Duffield 10% ownerWDAYWorkday, Inc.Planned sale$18.4M 98,446 shares at $187.07 48% of stakeTraded Oct 1 Filed Oct 5
-
Dianne Ledingham DirectorPEGAPegasystems Inc.Planned sale$34K 1,000 shares at $34.15 2.5% of stakeTraded Oct 1 Filed Oct 5
-
Patrick Fisher President, Global Limb ReconOFIXOrthofix Medical Inc.Planned sale$1,416 150 shares at $9.44 0.3% of stakeTraded Oct 1 Filed Oct 5
-
Bruce C Cozadd DirectorJAZZJazz Pharmaceuticals plcPlanned sale$1.4M 6,000 shares at $230.33 1.7% of stakeTraded Oct 1 Filed Oct 5
-
James M Roth Chief Revenue OfficerGTMZoomInfo Technologies Inc.Planned sale$77K 20,773 shares at $3.70 7.1% of stakeTraded Oct 2 Filed Oct 5
-
Ashley McGrane General Counsel and Corp SecGTMZoomInfo Technologies Inc.Planned sale$9,239 2,461 shares at $3.75 1.7% of stakeTraded Oct 2 Filed Oct 5
-
Rory P Read CEOCXMSprinklr, Inc.Planned sale$1.1M 203,666 shares at $5.17 6.2% of stakeTraded Oct 1 Filed Oct 5
-
Jennifer Vecchio Group President and CMOBURLBurlington Stores, Inc.Planned sale$456K 1,678 shares at $271.53 2.2% of stakeTraded Oct 1 Filed Oct 5
-
Carmen Amara Chief People OfficerYELPYelp Inc.Planned sale$9,300 500 shares at $18.60 0.5% of stakeTraded Oct 1 Filed Oct 5
About this data
- Officers, directors and anyone owning more than 10% of a company must report a trade in its stock on a Form 4 within two business days. We read each filing from SEC EDGAR and link to it on every row.
- Only open-market purchases and sales of common stock count here. Stock grants, option exercises, gifts and shares withheld or sold to pay taxes on vesting awards are not decisions to buy or sell, so they are left out.
- A planned sale was made under a Rule 10b5-1 trading plan, which the insider set up months in advance. Many executives sell this way on a schedule, so a planned sale says less than one made on the day.
- Values are shares times the price reported. When a filing amends an earlier one, the amended trades replace the originals. Related owners (a fund and its manager) who report the same trade separately are shown once.
- We cover the 4,792 US companies on our earnings calendar, with a year of history. The superinvestor notes count the featured 13F managers who added or cut the stock in their latest quarter.